Logo for HUTCHMED (China) Limited

HUTCHMED (China) Investor Relations Material

Latest events

Logo for HUTCHMED (China) Limited

H2 2024

HUTCHMED (China)
Logo for HUTCHMED (China)

H2 2024

19 Mar, 2025
Logo for HUTCHMED (China)

H1 2024

31 Jul, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from HUTCHMED (China) Limited

Access all reports
HUTCHMED Limited is a global biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. The company integrates innovative science and clinical expertise to develop a robust pipeline of therapies, leveraging its research and development capabilities in China and internationally. HUTCHMED markets its products in various regions and collaborates with global pharmaceutical partners for distribution and development. The company is headquartered in Hong Kong, China, and its shares are listed on the NASDAQ and the London Stock Exchange (LSE).